The first complex endovascular intervention for thoracic and abdominal aortic aneurysm (AAA) has been performed using ALLVAS, China's first endovascular intervention robot developed by Shanghai Aopeng Medical Technology Co. The procedures happened earlier this month at Changhai Hospital of China Naval Medical University by Professor Qing-Sheng Lu's team.
A total of three patients were treated with ALLVAS earlier this month at Changhai Hospital of China Naval Medical University by Professor Qing-Sheng Lu's team. All of them remained stable and recovered well after the minimally invasive surgery.
The ALLVAS Endovascular Interventional Surgery Robot is the world's first universal interventional surgery robot, built by Aopeng Medical through nearly a decade of forward-thinking technology planning. Aopeng's artificial intelligence robot-assisted interventional surgery will redefine 40 years of traditional minimally invasive interventional surgery.
While traditional surgical treatment for AAA can be challenging, the application of ALLVAS robotic-assisted technology enables precise positioning through digital technology to meet the individual needs of patients, helping doctors to achieve more satisfactory results and higher efficiency in clinical practice.
The technology behind Aopeng's endovascular interventional surgery robot comes from independent research and development and that has been applied for 35 invention patents. The system architecture adopts a humanoid multi-manipulator design to simulate the hand operations of doctors and their assistants, adapting to the needs of diverse interventional procedures, enabling catheter guidewire assistance for simple cases, and also coordinating stent release, tube and wire tracking and positioning, and endovascular intervention simulation for complex cases.
Endovascular repair is a minimally invasive surgical technique to treat thoracic/abdominal aortic aneurysms. Compared to the traditional open surgery, it is less invasive, allowing many high-risk patients who can’t tolerate open surgery the opportunity for life-saving surgery. Despite great progress in minimally invasive technology, interventional procedures haven’t changed much, presenting risks of radiation injury to the operator and difficulty in achieving precision. The emergence of the Aopeng endovascular intervention surgery robot ALLVAS has offered new opportunities in endovascular interventional treatment.
Aopeng's endovascular interventional surgery robot can treat coronary, peripheral, neurological and vascular tumors, covering a broader scope than the current interventional surgery robots in the market. It can be used in cardiology, vascular surgery, neurology, neurosurgery, and radiology departments in tertiary hospitals, which will greatly reduce the reliance on experience for interventional procedures and shorten the training time for junior physicians.
The endovascular interventional surgery robot will receive its registration certificate and start being used in clinical settings in 2023.Back To Top
First Patients Treated with Endovascular Intervention Robot. Appl Radiol.